Introduction
Yokenella regensburgei is an opportunistic human pathogen and is the only species of the genus Yokenella within the family Enterobacteriaceae (Stock et al., 2004; Abbott & Janda, 1994) . Previously, it was known as 'enteric group 45' and it was later renamed 'Koserella trabulsii' by the Centers for Disease Control and Prevention. The name Y. regensburgei assigned in 1984 by Kosako et al. (1984) was retained for this new genus and species. The epidemiological and clinical significance of this organism is not established. Y. regensburgei has been recovered from water from wells, food material (namely salad) and the intestinal tracts of insects and reptiles (Kosako et al., 1984) . It is rarely reported to cause human infections, with only sporadic case reports available in the literature. It has been isolated from humans, namely leg wound, blood, upper respiratory tract, urine, faecal and synovial fluid samples (Stock et al., 2004; Abbott & Janda, 1994; Kosako et al., 1984; Hickman-Brenner et al., 1985; Yagüe Muñoz et al., 1989) . Biochemically, Y. regensburgei closely resembles Hafnia alvei and Salmonella enterica (Stock et al., 2004) ; however, DNA relatedness values and other studies have revealed that they are distinct species (Kosako et al., 1984; Hickman-Brenner et al., 1985) .
Here, we present a case report of a bloodstream infection due to Y. regensburgei from India.
Case report
A 5-year-old male child presented to the paediatric outpatient department of Vardhman Mahavir Medical College and Safdarjung Hospital in October 2012 with continuous high-grade fever and chills that he had experienced for 7 days. The child looked unwell and had lost his appetite. There was no history of diarrhoea, abdominal pain, cough, dysuria or urinary frequency on admission. His body temperature was 101 u F and he had a respiratory rate of 40 min
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, blood pressure of 100/ 70 mmHg and a pulse rate of 102 beats min 21 . A systemic examination (respiratory, abdominal and neurological) revealed nothing of note. There was no history of any major illness in the past. The child was admitted and the cause of his fever was investigated. Laboratory data showed his haemoglobin level was 10.5 mg dl 21 and his total leukocyte count was 10 500 mml
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. The widal and typhidot tests were negative; a peripheral blood smear and a rapid test for malarial antigen were also negative. Urine culture showed no growth and an X-ray of the chest was normal. Blood cultures were sent as enteric fever was suspected. The first blood culture was negative after 48 h of incubation, hence another blood culture was taken. Both the blood cultures became positive, the first sample after 5 days and the second sample after 48 h of incubation. A preliminary result of non-lactose-fermenting (pale coloured) growth was reported to the clinician.
Identification and biochemical properties
Based on routine biochemical testing the organism was found to be a motile bacterium which was weakly positive for catalase, oxidase-negative and able to utilize citrate (positive after 48 h) and had a triple sugar iron reaction of K/A with gas (indole, H 2 S and urease not produced). The non-lactose-fermenting organism was presumptively identified as Salmonella enterica serovar Paratyphi A (S. Paratyphi). However, the organism failed to agglutinate with Salmonella polyvalent O antisera. Since the identification of the strain was not ascertained, it was confirmed usingand extensive biochemical tests were performed by Entero-18R (Liofilchem). The results were ONPG-negative, mannitol-positive, Vogues-Proskuer-negative and lysine-, ornithine-and arginine decarboxylase-positive. The organism was unable to ferment sucrose, raffinose, inositol, sorbitol and malonate. The aesculin and glycerol fermentation tests were performed manually and the results were negative ( Table 1 ). The identification of both isolates was confirmed by VITEK 2 (bioMérieux) and Entero 18R as Y. regensburgei.
Antimicrobial disc diffusion susceptibility test was performed as per the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI, 2012) and the organism was found to be sensitive to ampicillin, ceftazidime, cefotaxime, gentamicin, amikacin, netilmycin, ciprofloxacin, nalidixic acid, piperacillin-tazobactum and carbapenems, but was resistant to penicillin, cefoxitin and colistin. MICs were performed using the Etest (AB BIODISK); results are shown in Table 1 .
Extended-spectrum beta-lactamase detection was carried out by performing the double-disc diffusion test using cefotaxime and ceftazidime as per CLSI guidelines (CLSI, 2012); results were negative. Due to cefoxitin resistance along with susceptibility to third-generation cephalosporins, the isolate was presumed to have a chromosomal AmpC enzyme. DNA was extracted and PCR was performed using degenerate primer pair P1 (GGATTCCGGGTATGGCSGTNGC) and P4 (TCCCAGCCTARYCCCTGRTACAT), as described by Stock et al. (2004) , to detect the presence of genes encoding chromosomal and plasmid-mediated AmpC enzymes. A 750 bp amplification product for AmpC was obtained ( Fig.  1 ) and was sequenced, and further nucleotide and deduced amino acid sequences were analysed and compared with sequences available in GenBank at the National Centre for Biotechnology Information website (http://www.ncbi.nlm. nih.gov/).
Based on the susceptibility report, the child was treated with ciprofloxacin for 7 days. He responded clinically to the treatment. The child remained afebrile and he was discharged. No recurrence was reported on a follow-up 3 months later.
Discussion
The clinical significance of Y. regensburgei as a human pathogen is not well described. This may be attributed to a (Table 2) . Septic knee and transient bacteraemia (Abbott & Janda, 1994) , venous ulcer wound infection (Fajardo Olivares et al., 2005) , abdominal abscess and septic shock (Fill & Stephens, 2010) and soft tissue infection with bacteraemia (Lo et al., 2011) were the clinical diagnoses among these cases, and in none of these cases could the source of the infection be traced. An association between Y. regensburgei infection and some form of immune suppression has been observed in all these reports, such as alcohol intake, chronic renal failure, diabetes mellitus, adenocarcinoma and the use of steroids and immunosuppressive agents. Furthermore, all cases were reported in adults or elderly patients. Isolation of this species from water from wells, insect intestines, human upper respiratory tract, faeces and urine may suggest its ability to survive in these locations; however, the source and route of transmission is unclear (Kosako et al., 1984; Hickman-Brenner et al., 1985) .
The present case involved a paediatric patient who was apparently immunocompetent. Undoubtedly, isolation of Y. regensburgei in pure growth from two separate blood culture samples on separate days implicates the plausible pathogenic role of this organism, as was also recently reported by Lo et al. (2011) . The child had no other localized signs of infection. In addition, the clinical response to ciprofloxacin therapy also supports the clinical relevance of this species. Similar success with fluoroquinolone therapy has also been demonstrated in two previous cases of transient bacteraemia and perimalleolar ulcer (Abbott & Janda, 1994; Fajardo Olivares et al., 2005) . The source of infection could not be traced. The absence of similar symptoms amongst other family members possibly excludes infection through contaminated food and water. History of recent animal contact could not be ascertained.
The child presented with a clinical picture of enteric fever, and phenotypically the organism was presumptively identified as S. Paratyphi A. However, the unusual feature was its susceptibility to nalidixic acid, while the majority of both Salmonella enterica serovar Typhi (S. Typhi) and S. Paratyphi A strains isolated in the Indian subcontinent are currently nalidixic acid resistant (Gaind et al., 2006; Raveendran et al., 2008) . Important identification features of the species Y. regensbergei that can distinguish it from Salmonella and Hafnia alvei are results from the Simmons' citrate assimilation test, a negative Voges-Proskauer reaction and fermentation of melibiose, cellobiose and glycerol (Hickman-Brenner et al., 1985) .
The species appeared to be of low virulence as specific treatment (ciprofloxacin) was initiated only after 8 days of presentation when blood cultures revealed Y. regensburgei. However, the child's condition did not deteriorate during this period and he recovered without any complications. The organism was susceptible to a variety of antimicrobial agents including fluoroquinolones and third-generation cephalosporins, which are used to manage patient conditions. The isolate was in vitro susceptible to ampicillin, piperacillin, cephalosporins and carbapenems, as well as to a beta-lactamase inhibitor combination (amoxicillin-clavulanate, piperacillin-tazobactam, cefoperazone-sulbactam), quinolones and aminoglycosides. As reported previously, the strain was resistant to penicillin, cefoxitin and colistin (Hickman-Brenner et al., 1985; Richard, 1989) . On characterizing 10 strains of Y. regensburgei from various clinical and environmental sources, Stock et al. (2004) found that the species possesses AmpC genes, closely related to the chromosomal AmpC of Enterobacter and Citrobacter species, and expresses highly inducible and potent beta-lactamases, and is therefore naturally resistant to a variety of first-and second-generation cephalosporins and cefoxin, but is relatively susceptible to third-generation cephalosporins (Stock et al., 2004) . However, using broth dilution, Stock et al. (2004) have reported medium-dependent susceptibility among several beta-lactams including narrow-spectrum cephalosporins with IsoSensitest broth. In this report, the MIC of amoxicillin ranged from 1 to 16 mg ml
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. Our isolate was susceptible to ampicillin with an MIC of 1.5 mg ml 21 using the Etest. The colistin susceptibility test can be a useful screening test for the identification of Y. regensburgei, as the species is often resistant to colistin, while other Enterobacteriaceae members are uniformly sensitive to colistin, except the tribe Proteae and Serratia species.
To the best of our knowledge, this is the first report from India of Y. regensburgei infection. Important highlights of this case were the clinical resemblance to enteric fever and presentation in a paediatric patient who had an apparent immunocompetent status. Due to the lack of adequate diagnostic facilities in the form of automated and extended biochemical tests in many laboratories, this species may be overlooked, and hence the true incidence of human infection due to this species may not be known. Clinical laboratories should, however, attempt to identify the 
S. Jain and others 938
Journal of Medical Microbiology 62 organism, as further reports will aid in establishing the clinical and epidemiological significance of this rarely reported member of Enterobacteriaceae.
